TP53 and neoplasm: On the other hand, the enhanced migratory response of HER2/neu+ tumor cells to SAA1, SAA2, and THBS4 (Fig. 4c, d) suggests that stromal mutant p53 may predispose tumors to metastasis at earlier stages.